CNTA
Centessa Pharmaceuticals
CNTA
CNTA
44 hedge funds and large institutions have $669M invested in Centessa Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
17% less capital invested
Capital invested by funds: $808M → $669M (-$139M)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Holders
44
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$16.5M | |
| 2 | +$11.7M | |
| 3 | +$5.34M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.05M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$3.86M |
Top Sellers
| 1 | -$6.42M | |
| 2 | -$4.5M | |
| 3 | -$3.84M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$3.18M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.71M |